WHO commends Rwanda's commitment to eliminate cervical cancer by 2030
Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation (WHO), praised Rwanda for its dedication to eradicating cervical cancer by 2030.
His commendation followed the Rwanda Biomedical Centre's announcement detailing intentions to meet the 90-70-90 targets for cervical cancer elimination by 2027, ahead of WHO's global objective.
These benchmarks aim for 90% vaccination of girls against HPV by age 15, 70% screening of women at ages 35 and 45, and 90% treatment for those testing positive for cervical cancer.
Dr Tedros conveyed optimism in his statement, remarking on Rwanda's swift progress, particularly noting the country's achievements with the HPV vaccine since its introduction in 2011, which now boasts a coverage of 90%.
He highlighted that two of Rwanda’s districts are already meeting these ambitious targets. To ensure these goals are met, he emphasised the importance of robust political leadership alongside a comprehensive strategy that includes vaccination, screening, and treatment.
Further demonstrating its commitment, Rwanda plans to deploy a single-dose HPV vaccine this year, enhancing its vaccination efforts for cervical cancer.
Dr. Tedros pointed out that these targets are not merely aspirational but, with collective effort, fully attainable, even in low-income regions. He cited the successes of Bhutan and Nigeria in achieving significant vaccination rates as exemplary models in the global fight against cervical cancer.
